Search results for "Cardiovascular events"
Emphasize exercise for CAD testing, disease prevention
Exercise capacity is the single most power predictor of cardiovascular events, whether or not symptoms are present.
https://immattersacp.org/archives/2014/06/CAD.htm
1 Jun 2014
Trial of apixaban with single and combination antiplatelet therapy in ACS stopped early due to observed increase in major bleeding events
Full-dose anticoagulation, in combination with antiplatelet therapy of any kind in patients with acute coronary syndrome, results in substantial bleeding without any clear additional benefit and should only be considered when required for another condition.
https://immattersacp.org/weekly/archives/2015/08/11/4.htm
11 Aug 2015
Changes to contraindication for statins in pregnancy
This column reviews details on recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2021/09/changes-to-contraindication-for-statins-in-pregnancy.htm
1 Sep 2021
Warning on HCV treatments; more cancer drugs approved
This update also covers a warning that combination drugs can cause serious liver injury and approval of new drugs for metastatic non-small-cell lung cancer that has progressed after other treatments.
https://immattersacp.org/archives/2016/01/fda.htm
1 Jan 2016
Lupus presentation may be an ‘imitator’
Lupus can involve multiple organ systems and shares the same, sometimes nonspecific presentation as other conditions. But a diligent internist##mdash;an “excellent generalist” in the words of one expert##mdash;can pick up on the correct diagnosis.
https://immattersacp.org/archives/2014/11/lupus.htm
1 Nov 2014
Updated guidance issued on treatment of hypertension in patients with CAD
The American Heart Association, American College of Cardiology, and American Society of Hypertension released updated guidance last week on treatment of hypertension in patients with coronary artery disease (CAD).
https://immattersacp.org/weekly/archives/2015/04/07/5.htm
7 Apr 2015
Task Force recommends aspirin for primary prevention of CVD, colorectal cancer
The Task Force recommended that low-dose aspirin be initiated for the primary prevention of CVD and colorectal cancer in adults ages 50 to 59 years who have a 10% or greater 10-year CVD risk, are not at increased risk for bleeding, have a life expectancy of at least 10 years, and are willing to take low-dose aspirin daily for at least 10 years.
https://immattersacp.org/weekly/archives/2016/04/12/1.htm
12 Apr 2016
Non-HDL cholesterol may be best marker of cardiovascular risk in statin-treated patients
Non-high-density lipoprotein cholesterol may be a better marker of cardiovascular risk in patients taking statins than low-density lipoprotein cholesterol or apolipoprotein B, according to a new study.
https://immattersacp.org/weekly/archives/2012/04/03/4.htm
3 Apr 2012
Azithromycin gets warning, incretin mimetics investigated
This regulatory update covers a new warning on azithromycin about abnormal changes in the electrical activity of the heart, and a possible increased risk of pancreatitis and precancerous findings from incretin mimetic drugs.
https://immattersacp.org/archives/2013/05/fda.htm
1 May 2013
Screening for PTSD after life-threatening medical events
Internists are in position to screen for and spot signs of post-traumatic stress disorder following life-threatening medical events such as heart attack and stroke. Yet this is not always part of usual care.
https://immattersacp.org/archives/2015/11/ptsd.htm
1 Nov 2015